ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 127 filers reported holding ARCELLX INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,800,189 | +9.8% | 4,537,352 | -3.3% | 0.01% | +16.7% |
| Q2 2023 | $148,329,357 | -10.3% | 4,690,998 | -12.6% | 0.01% | +50.0% |
| Q1 2023 | $165,332,004 | +312.5% | 5,366,180 | +314.8% | 0.01% | +100.0% |
| Q4 2022 | $40,075,728 | +170.7% | 1,293,600 | +64.0% | 0.00% | +100.0% |
| Q3 2022 | $14,803,000 | +31.3% | 788,668 | +26.4% | 0.00% | +100.0% |
| Q2 2022 | $11,277,000 | – | 623,718 | +4797730.8% | 0.00% | – |
| Q1 2022 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |